- Home
- GTX vs CNTA Comparison
GTX vs CNTA Comparison
Compare GTX & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTX
- CNTA
- Stock Information
- Founded
- GTX 2018
- CNTA 2020
- Country
- GTX Switzerland
- CNTA United Kingdom
- Employees
- GTX N/A
- CNTA N/A
- Industry
- GTX Auto Parts:O.E.M.
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- GTX Consumer Discretionary
- CNTA Health Care
- Exchange
- GTX Nasdaq
- CNTA Nasdaq
- Market Cap
- GTX 2.0B
- CNTA 1.9B
- IPO Year
- GTX N/A
- CNTA 2021
- Fundamental
- Price
- GTX $12.94
- CNTA $15.41
- Analyst Decision
- GTX Strong Buy
- CNTA Strong Buy
- Analyst Count
- GTX 1
- CNTA 11
- Target Price
- GTX $14.00
- CNTA $28.90
- AVG Volume (30 Days)
- GTX 3.1M
- CNTA 918.3K
- Earning Date
- GTX 07-24-2025
- CNTA 08-12-2025
- Dividend Yield
- GTX 1.85%
- CNTA N/A
- EPS Growth
- GTX 42.92
- CNTA N/A
- EPS
- GTX 1.43
- CNTA N/A
- Revenue
- GTX $3,461,000,000.00
- CNTA $15,000,000.00
- Revenue This Year
- GTX $2.27
- CNTA N/A
- Revenue Next Year
- GTX $0.06
- CNTA N/A
- P/E Ratio
- GTX $9.08
- CNTA N/A
- Revenue Growth
- GTX N/A
- CNTA 118.88
- 52 Week Low
- GTX $7.02
- CNTA $9.10
- 52 Week High
- GTX $13.08
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- GTX 76.44
- CNTA 60.38
- Support Level
- GTX $11.43
- CNTA $13.22
- Resistance Level
- GTX $11.95
- CNTA $16.43
- Average True Range (ATR)
- GTX 0.39
- CNTA 0.67
- MACD
- GTX 0.12
- CNTA 0.03
- Stochastic Oscillator
- GTX 93.27
- CNTA 66.45
About GTX Garrett Motion Inc.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.